secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001193125-25-100522
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet appoints Ashley McEvoy CEO, expects Q1 revenue above guidance, raising FY outlook
--------------------------------------------------------------------------------

- Ashley McEvoy appointed President and CEO effective April 28; succeeds Jim Hollingshead, who resigned from Board.
- McEvoy was EVP and Worldwide Chairman of J&J MedTech ($30B+ revenue); also served on P&G Board.
- Hollingshead terminated without cause; severance includes 2x salary ($2.3M), 2x bonus, vested 7,233 unvested RSUs.
- Insulet expects to exceed Q1 revenue guidance and will raise full-year 2025 guidance; full results on May 8.
- Investor Day postponed from June 5; new date to be announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000119312525100522/0001193125-25-100522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000119312525100522/d926293d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-100522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer